BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28159363)

  • 1. Do the European Medicines Agency Decisions Hurt Pediatric Melanoma Patients?
    Rose K; Walson PD
    Clin Ther; 2017 Feb; 39(2):253-265. PubMed ID: 28159363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
    Rose K
    Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contributions of the European Medicines Agency and its pediatric committee to the fight against childhood leukemia.
    Rose K; Walson PD
    Risk Manag Healthc Policy; 2015; 8():185-205. PubMed ID: 26604845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug development: EU paediatric legislation, the European Medicines Agency and its Paediatric Committee--adolescents' melanoma as a paradigm.
    Rose K; Senn S
    Pharm Stat; 2014; 13(4):211-3. PubMed ID: 24903307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric investigation plans for specific immunotherapy: Questionable contributions to childhood health.
    Rose K; Kopp MV
    Pediatr Allergy Immunol; 2015 Dec; 26(8):695-701. PubMed ID: 26495999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric Melanoma and Drug Development.
    Rose K; Grant-Kels JM
    Children (Basel); 2018 Mar; 5(3):. PubMed ID: 29558389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do Paediatric Investigation Plans (PIPs) Advance Paediatric Healthcare?
    Rose K; Walson PD
    Paediatr Drugs; 2017 Dec; 19(6):515-522. PubMed ID: 28889403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Children with multiple sclerosis should not become therapeutic hostages.
    Rose K; Müller T
    Ther Adv Neurol Disord; 2016 Sep; 9(5):389-95. PubMed ID: 27582894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic Fibrosis Treatment: A Paradigm for New Pediatric Medicines, Globalization of Drug Development and the Role of the European Medicines Agency.
    Rose K; Spigarelli MG
    Children (Basel); 2015 Mar; 2(1):108-30. PubMed ID: 27417354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Ethical Challenge for Institutional Review Boards (IRBs)/Ethics Committees (ECs) in the Assessment of Pediatric Clinical Trials.
    Rose K; Kummer H
    Children (Basel); 2015 May; 2(2):198-210. PubMed ID: 27417359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enabling Development of Paediatric Medicines in Europe: 10 Years of the EU Paediatric Regulation.
    Tomasi PA; Egger GF; Pallidis C; Saint-Raymond A
    Paediatr Drugs; 2017 Dec; 19(6):505-513. PubMed ID: 28900869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of Pediatric Drug Development: Regulatory and Practical Frameworks.
    Tsukamoto K; Carroll KA; Onishi T; Matsumaru N; Brasseur D; Nakamura H
    Clin Ther; 2016 Mar; 38(3):574-81. PubMed ID: 26869192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Questionable Industry-Sponsored Postneonatal Pediatric Studies in Slovenia.
    Rose K; Neubauer D; Grant-Kels JM
    Curr Ther Res Clin Exp; 2019; 90():86-91. PubMed ID: 31388360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile animal studies and pediatric drug development: a European regulatory perspective.
    Carleer J; Karres J
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):254-60. PubMed ID: 21638754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study.
    Hwang TJ; Tomasi PA; Bourgeois FT
    PLoS Med; 2018 Mar; 15(3):e1002520. PubMed ID: 29494592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Drugs for Rare Diseases in Children.
    Rose K
    Clin Ther; 2017 Feb; 39(2):246-252. PubMed ID: 28161117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrapolation in the development of paediatric medicines: examples from approvals for biological treatments for paediatric chronic immune-mediated inflammatory diseases.
    Stefanska AM; Distlerová D; Musaus J; Olski TM; Dunder K; Salmonson T; Mentzer D; Müller-Berghaus J; Hemmings R; Veselý R
    Arch Dis Child; 2017 Oct; 102(10):952-957. PubMed ID: 28554892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of the scope of European Union paediatric investigation plans with corresponding orphan designations.
    Ecker A; Mariz S; Naumann-Winter F; Norga K; Barisic I; Girard T; Tomasi P; Mentzer D; Sepodes B
    Arch Dis Child; 2018 May; 103(5):427-430. PubMed ID: 29089318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Too Many Avoidable Suicides Occur Worldwide in Young Patients.
    Rose K; Neubauer D; Grant-Kels JM
    Rambam Maimonides Med J; 2019 Oct; 10(4):. PubMed ID: 31545703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.